Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one

Provided herein are formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one.

Saved in:
Bibliographic Details
Main Authors VISKY DORA, LEONG WILLIAM WEI-HWA, PARIKH DARSHAN K, BOERSEN NATHAN, XU JEAN, MENON ANIL, LI YING, LEE THOMAS, LIANG XIAOZHANG, KREILEIN MATTHEW MICHAEL, COHEN BENJAMIN
Format Patent
LanguageEnglish
Published 07.06.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract Provided herein are formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one.
AbstractList Provided herein are formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one.
Author COHEN BENJAMIN
LEE THOMAS
LIANG XIAOZHANG
KREILEIN MATTHEW MICHAEL
MENON ANIL
PARIKH DARSHAN K
VISKY DORA
LEONG WILLIAM WEI-HWA
BOERSEN NATHAN
LI YING
XU JEAN
Author_xml – fullname: VISKY DORA
– fullname: LEONG WILLIAM WEI-HWA
– fullname: PARIKH DARSHAN K
– fullname: BOERSEN NATHAN
– fullname: XU JEAN
– fullname: MENON ANIL
– fullname: LI YING
– fullname: LEE THOMAS
– fullname: LIANG XIAOZHANG
– fullname: KREILEIN MATTHEW MICHAEL
– fullname: COHEN BENJAMIN
BookMark eNqNjz1uwzAMhT20Q9rmDhwTwBws5QdZU7TIWCDNFBSBatGxAFk0RHlwjtbTVU1ygE58Dx8f8fhUPAQONCl-PloTO1PTkFxtPDQcu8Gb5DhICX3kmkQoS2Hv7BULmGCho9SyFeAGBiGI9BcKZ0gMFWY2elzjTGF30yucVTusSlUuMEVnLuxR4-jn_RiddeFmUGdsXTvayBmYiwt8VKXG7y-4e1T50Bxz-ZfisTFeaHqfzwW8v32-7pB6PpH0-alA6XTYb_Ryo1eLrdL_WPkFjGFbNA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US9359364B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US9359364B23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:51:13 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US9359364B23
Notes Application Number: US201414254023
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160607&DB=EPODOC&CC=US&NR=9359364B2
ParticipantIDs epo_espacenet_US9359364B2
PublicationCentury 2000
PublicationDate 20160607
PublicationDateYYYYMMDD 2016-06-07
PublicationDate_xml – month: 06
  year: 2016
  text: 20160607
  day: 07
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies SIGNAL PHARMACEUTICALS, LLC
RelatedCompanies_xml – name: SIGNAL PHARMACEUTICALS, LLC
Score 3.043877
Snippet Provided herein are formulations, processes, solid forms and methods of use relating to...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160607&DB=EPODOC&locale=&CC=US&NR=9359364B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8NADD_GFPVNp-L84h6kbNDg-rG2Pgxh7cYQ9oHbZCAy1vbmCrMta4fUP82_zlzbzb3oW64peUiaS-6a_ELInczmij5jEmAsroFquDYYdVUF3cDgZdc0Vk-xO7s9rTNWnyb1SYF4m16YFCf0MwVHRI9y0N_jdL8Ofy-xrLS2Mrq3PXwUPLZHDUvIT8cSpuM1XbCajdagb_VNwTQb46HQe27wBlRFU5u4W-_xLJrD7LdemrwpJdyNKO1jsj9AYX58QgrML5FDczN4rUQOuvn_biRz14tOyfdgsXv7THmymY_eikQaZvX-DEn8mDw3ZUd05rs0mxEd0WBO1xGjWfOK_07jgEqAvGQJOlRk-MhoDSpSByRRFlXgIz2-giUokCyrYbLyMNBlC1CQ7XqLxF0FyOAY1cGrLCpgv9F8DTIKqkLgszNC262R2QFUwnSr8Ol4uFWXck6KPr55QajjYPKHp4uZPtNVVpsbaEuOlsW0uezozkOZlP8Uc_kP74occcul9Vf6NSnGqzW7wUgf27epjX4ABdGtNw
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsJAcEPQiDdFjfjcgyGQMJE-6OKBmFAgqLwiYEiMIX0s0gRbQksMfppf53RbkIveZnc2c5jp7Mxs50HIjcwnCjO4BGiLi6CWbRPKJVUFVkbjZRY1XhK9O9sdrTlUH0elUYI461oY0Sf0UzRHRI2yUN8DcV_Pfx-xaiK30r81Hdzy7huDSi0bR8cSuuNFlq1VK_Vet9bVs7peGfaznedKWICqaGoVb-sdhhGhiJReqmFRynzbojQOyG4PibnBIUlwN01S-nrwWprsteP_3QjGqucfke_edPv1mYbOZjx6yy_QeZTvzxHEj8mxBdqnhmvTaEa0T70JXfqcRsUr7jsNPCoB4lYzYJCT4SOCNchJTZAKckGFcKTHlzcDBVaz_Hy1cNDQRQtQEG0705W98BAR9qj2XuWCAuYbjdcgI6E8eC4_JrRRH-hNQCaMNwwfD_sbdiknJOniyVNCLQudP4wuDGYwlRcnZZRl2C2LaxPZYtZdhmT-JHP2D-6apJqDdmvceug8nZP9UIoiF4tdkGSwWPJLtPqBeSXk9QNFcbAh
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pharmaceutical+formulations%2C+processes%2C+solid+forms+and+methods+of+use+relating+to+1-ethyl-7-%282-methyl-6-%281H-1%2C2%2C4-triazol-3-yl%29pyridin-3-yl%29-3%2C4-dihydropyrazino%5B2%2C3-b%5D+pyrazin-2%281H%29-one&rft.inventor=VISKY+DORA&rft.inventor=LEONG+WILLIAM+WEI-HWA&rft.inventor=PARIKH+DARSHAN+K&rft.inventor=BOERSEN+NATHAN&rft.inventor=XU+JEAN&rft.inventor=MENON+ANIL&rft.inventor=LI+YING&rft.inventor=LEE+THOMAS&rft.inventor=LIANG+XIAOZHANG&rft.inventor=KREILEIN+MATTHEW+MICHAEL&rft.inventor=COHEN+BENJAMIN&rft.date=2016-06-07&rft.externalDBID=B2&rft.externalDocID=US9359364B2